AMC Stock Price: AMC Entertainment jumps 5.73% to settle above $40 mark


  • NYSE:AMC extends advance on Thursday as Wall Street runs on earnings reports.
  • #AMCSqueeze is trending again as the SEC investigates Citadel.
  • A slew of new releases in theaters should keep AMC’s momentum going.

Update October 15: NYSE:AMC extended its rebound from five-day lows of $36.12 into the second straight day on Thursday. AMC shares gained 5.70% on the day, clinching fresh ten-day highs at $41.10 before reversing to $40.07 at the close. Thursday’s turnaround on Wall Street underpinned the sentiment around AMC shares, as top American banks reported strong corporate earnings for the third quarter. Further, the US PPI missed expectations and arrived at 8.6% YoY in September, easing off the inflationary worries and providing additional optimism.

 

NYSE:AMC has extended its recent trend as the stock continues to find support after free-falling for the past month. On Wednesday, shares of AMC gained a further 2.96% and closed the trading session at $37.91. There has been some mounting momentum for the meme stock as of late, as the buzz in internet chat rooms and Reddit boards is pointing towards another attempt at a short squeeze. Rising alongside AMC was the original meme stock GameStop (NYSE:GME) which gained 4.66% during Wednesday’s session. Other meme stocks didn’t fare as well after squeezing on Tuesday, as Koss (NASDAQ:KOSS), SmileDirectClub (NASDAQ:SDC), and Camber Energy (NYSEAMERICAN:CEI) all traded lower. 


Stay up to speed with hot stocks' news!


AMC apes were once again able to get the hashtag #AMCSqueeze trending on social media on Wednesday. The surge in mentions came as the result of an announcement that the SEC is initiating an investigation into Citadel Securities, which is public enemy number one for retail investors. The investigation will look into Citadel’s business practices, which may include things like short selling stocks as well as its relationship with pay to order flow brokerages like Robinhood (NASDAQ:HOOD). 

AMC stock forecast

AMC Stock

AMC’s stock should be helped out by strong quarter over quarter and year over year comparisons from the third and fourth quarters of 2020. A slew of new Hollywood movies are set to hit theaters over the next couple of weeks, including the new Halloween Kills film that is kicking off the Halloween season. It should be another big weekend next week as the long awaited Dune film will hit theaters starting on October 22nd.

Previous updates

Update: NYSE:AMC closed Thursday at $40.7 per share, up by 5.73%. Wall Street posted a nice comeback on the back of solid Q3 earnings reports from big names. At the same time, US government bond yields edged lower, with the dollar down to the benefit of high-yielding rivals. The NYSE Composite finished the day up 206 points or 1.25%, with all US major indexes settling in the green. 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

AUD/USD: A minor support emerges around 0.6480

AUD/USD: A minor support emerges around 0.6480

AUD/USD added to Friday’s retracement, returning to the 0.6550 zone amid the persistent move higher in the US Dollar and the resumption of trade concerns. The Australian Dollar is expected to closely follow the release of critical hard data from China on Tuesday.

EUR/USD: Downward pressure losing impulse?

EUR/USD: Downward pressure losing impulse?

EUR/USD traded in the red for the fourth day in a row, this time retreating to three-week troughs in the mid-1.1600 on the back of the firmer tone in the Greenback and renewed trade effervescence between the US and the European Union.

Gold battling around $3,350 amid fresh tariffs’ threats

Gold battling around $3,350 amid fresh tariffs’ threats

Gold prices maintain their bearish tilt around the $3,350 zone per troy ounce, leaving behind three consecutive days of gains. Fresh trade concerns seem to temper the precious metal’s decline, but investors remain cautious ahead of the publication of US inflation data on Tuesday and the US Dollar's continued strong tone.

Hyperliquid Price Forecast: HYPE eyes gains following Sonnet BioTherapeutics' rebrand

Hyperliquid Price Forecast: HYPE eyes gains following Sonnet BioTherapeutics' rebrand

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a merger agreement with Rorschach I LLC to launch as a new HYPE treasury company, Hyperliquid Strategies Inc.

Five fundamentals for the week: Investors eye tariff circus and US inflation data

Five fundamentals for the week: Investors eye tariff circus and US inflation data Premium

Which country will be the next to receive a letter from America? US  President Donald Trump has been extending his tariff threats through the weekend. Has the US economy felt the consequences of levies already imposed? These are the topics for another hot summer month.

Best Brokers for EUR/USD Trading

Best Brokers for EUR/USD Trading

SPONSORED Discover the top brokers for trading EUR/USD in 2025. Our list features brokers with competitive spreads, fast execution, and powerful platforms. Whether you're a beginner or an expert, find the right partner to navigate the dynamic Forex market.

Forex MAJORS

Cryptocurrencies

Signatures

Best Brokers of 2025